Evome Medical Technologies Inc. (TSXV:EVMT)

TSXV:EVMT Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Feb 28, 2022	Dec 31, 2021	Feb 28, 2021
Cash & Equivalents	1.41	0.92	1.93	8.06	4.47	7.08
Short-Term Investments	-	-	-	-	-	0.49
Cash & Short-Term Investments	1.41	0.92	1.93	8.06	4.47	7.57
Cash Growth	34.25%	-52.36%	-76.06%	80.40%	-41.00%	-9.34%
Accounts Receivable	4.72	7.8	6.35	6.36	6.1	-
Other Receivables	-	-	-	0.23	-	-
Receivables	4.72	7.8	6.35	6.6	6.1	-
Inventory	9.26	10.24	8.1	4.97	5.03	-
Prepaid Expenses	2.02	2.04	0.22	0.41	0.1	0.14
Restricted Cash	-	-	-	-	-	5.43
Total Current Assets	17.42	21	16.6	20.04	15.71	13.13
Property, Plant & Equipment	9.12	13.06	11.18	5.4	5.49	-
Goodwill	4.96	6.4	13.7	9.83	14.83	-
Other Intangible Assets	2.84	7.03	9.38	6.93	7.03	-
Long-Term Accounts Receivable	-	-	0.19	-	-	-
Other Long-Term Assets	0.8	0.77	1.01	0.48	0.48	-
Total Assets	35.13	48.26	52.05	42.68	43.54	13.13

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Feb 28, 2022	Dec 31, 2021	Feb 28, 2021
Accounts Payable	6.02	6.91	5.27	2.86	2.67	0.48
Accrued Expenses	1.8	1.75	1.37	0.82	0.18	0.57
Short-Term Debt	3.96	6.11	5.16	5.5	5.05	-
Current Portion of Long-Term Debt	7.99	10.41	0.2	0.17	0.17	-
Current Portion of Leases	0.82	1.48	0.85	0.25	0.22	-
Other Current Liabilities	13.27	10.9	17.31	13.56	19.89	5.44
Total Current Liabilities	33.86	37.57	30.16	23.16	28.18	6.49
Long-Term Debt	0.46	0.26	0.57	0.68	0.71	-
Long-Term Leases	4.23	6.43	5.98	3.93	3.99	-
Long-Term Deferred Tax Liabilities	-	-	-	1.76	1.9	-
Total Liabilities	38.56	44.25	36.72	29.53	34.78	6.49

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Feb 28, 2022	Dec 31, 2021	Feb 28, 2021
Common Stock	53.91	53.51	40.57	38.53	37.03	31.07
Additional Paid-In Capital	9.08	9.74	8.07	6.99	4.33	3.63
Retained Earnings	-72.58	-64.86	-49.26	-33.36	-33.15	-28.99
Comprehensive Income & Other	6.16	5.62	15.95	1.01	0.55	0.94
Shareholders' Equity	-3.43	4	15.33	13.15	8.76	6.64
Total Liabilities & Equity	35.13	48.26	52.05	42.68	43.54	13.13

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Feb 28, 2022	Dec 31, 2021	Feb 28, 2021
Total Debt	17.47	24.69	12.76	10.53	10.15	-
Net Cash (Debt)	-16.05	-23.77	-10.83	-2.48	-5.68	7.57
Net Cash Growth	-	-	-	-	-	-9.34%
Net Cash Per Share	-0.18	-0.32	-0.20	-0.06	-0.13	0.22
Filing Date Shares Outstanding	82.63	78.89	69.87	54.35	42.81	33.81
Total Common Shares Outstanding	82.63	79.89	57.11	53.89	42.81	33.81
Working Capital	-16.44	-16.57	-13.56	-3.12	-12.47	6.64
Book Value Per Share	-0.04	0.05	0.27	0.24	0.20	0.20
Tangible Book Value	-11.22	-9.42	-7.74	-3.61	-13.1	6.64
Tangible Book Value Per Share	-0.14	-0.12	-0.14	-0.07	-0.31	0.20
Machinery	4.16	4.43	3.71	1.53	1.52	-
Leasehold Improvements	0.34	0.56	0.15	0.13	0.13	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error